Keyword → DXC

Wall Street Braces for AI Disruption and Key Jobs Data in Market Week Ahead

U.S. markets are entering a pivotal week with artificial intelligence disruption looming large over investor expectations and volatility. As traders await critical jobs and inflation data, shifting sentiment on AI’s role in corporate spending is expected to influence sector performance and drive stock rotation across major indices.

Medtronic Posts Strongest Revenue Growth in Ten Quarters, Reiterates Full-Year Outlook

Medtronic reported third-quarter fiscal 2026 revenue of $9.02 billion, an 8.7% year-over-year increase representing the company's highest enterprise revenue growth in ten quarters, beating analyst estimates of $8.89 billion. Non-GAAP diluted EPS of $1.36 beat consensus by three cents, and the medical device giant reiterated full-year organic revenue growth guidance of approximately 5.5% despite a projected $185 million tariff headwind.

Palo Alto Networks Reports Fiscal Q2 After Close as Cybersecurity Sector Watches Platformization Metrics

Palo Alto Networks is set to release fiscal second-quarter 2026 results after U.S. markets close Tuesday, with analysts projecting revenue of approximately $2.58 billion and non-GAAP EPS of $0.93 to $0.95. Investors will closely scrutinize Next-Generation Security ARR growth and customer platformization adoption as key indicators of the cybersecurity giant's long-term trajectory amid a decelerating top-line growth backdrop and intensifying enterprise software competition.